Terms: = Lung cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
2280 results:
1. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in lung Adenocarcinoma and Squamous Cell Carcinoma.
Koh YW; Han JH; Haam S; Lee HW
Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
[TBL] [Abstract] [Full Text] [Related]
3. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in lung cancer.
Shao J; Xu Y; Olsen RJ; Kasparian S; Sun K; Mathur S; Zhang J; He C; Chen SH; Bernicker EH; Li Z
Cells; 2024 Apr; 13(8):. PubMed ID: 38667328
[TBL] [Abstract] [Full Text] [Related]
4. Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.
Zheng L; Hu F; Huang L; Lu J; Yang X; Xu J; Wang S; Shen Y; Zhong R; Chu T; Zhang W; Li Y; Zheng X; Han B; Zhong H; Nie W; Zhang X
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38641349
[TBL] [Abstract] [Full Text] [Related]
5. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
Wang B; Hou C; Yu X; Liu J; Wang J
Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
[TBL] [Abstract] [Full Text] [Related]
7. Architecting the metabolic reprogramming survival risk framework in LUAD through single-cell landscape analysis: three-stage ensemble learning with genetic algorithm optimization.
Sun X; Nong M; Meng F; Sun X; Jiang L; Li Z; Zhang P
J Transl Med; 2024 Apr; 22(1):353. PubMed ID: 38622716
[TBL] [Abstract] [Full Text] [Related]
8. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568
[TBL] [Abstract] [Full Text] [Related]
10. Network-based identification of key proteins and repositioning of drugs for non-small cell lung cancer.
Adeyemo OM; Ashimiyu-Abdusalam Z; Adewunmi M; Ayano TA; Sohaib M; Abdel-Salam R
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2031. PubMed ID: 38600056
[TBL] [Abstract] [Full Text] [Related]
11. Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study.
Qu W; Chen C; Cai C; Gong M; Luo Q; Song Y; Yang M; Shi M
Front Immunol; 2024; 15():1327779. PubMed ID: 38596674
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma.
Li Z; Lu W; Yin F; Zeng P; Li H; Huang A
J Transl Med; 2024 Apr; 22(1):340. PubMed ID: 38594779
[TBL] [Abstract] [Full Text] [Related]
13. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Smit EF; Felip E; Uprety D; Nagasaka M; Nakagawa K; Paz-Ares Rodríguez L; Pacheco JM; Li BT; Planchard D; Baik C; Goto Y; Murakami H; Saltos A; Pereira K; Taguchi A; Cheng Y; Yan Q; Feng W; Tsuchihashi Z; Jänne PA
Lancet Oncol; 2024 Apr; 25(4):439-454. PubMed ID: 38547891
[TBL] [Abstract] [Full Text] [Related]
14. Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation.
Huang H; Chen H; Zheng D; Chen C; Wang Y; Xu L; Wang Y; He X; Yang Y; Li W
Cancer Imaging; 2024 Mar; 24(1):44. PubMed ID: 38532520
[TBL] [Abstract] [Full Text] [Related]
15. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
[TBL] [Abstract] [Full Text] [Related]
16. Correlation between morphological parameters and dosimetric parameters of the heart and spinal cord in the intermediate- and advanced-stage esophageal cancer.
Zhao W; Lan L; Xu B; Chen D; Zeng Y; Guo F; Zhang H
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2015. PubMed ID: 38488482
[TBL] [Abstract] [Full Text] [Related]
17. Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy.
Bar J; Leibowitz R; Reinmuth N; Ammendola A; Jacob E; Moskovitz M; Levy-Barda A; Lotem M; Katsenelson R; Agbarya A; Abu-Amna M; Gottfried M; Harkovsky T; Wolf I; Tepper E; Loewenthal G; Yellin B; Brody Y; Dahan N; Yanko M; Lahav C; Harel M; Raveh Shoval S; Elon Y; Sela I; Dicker AP; Shaked Y
Front Immunol; 2024; 15():1364473. PubMed ID: 38487531
[TBL] [Abstract] [Full Text] [Related]
18. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-cancer Clinicogenomic Data set.
Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
[TBL] [Abstract] [Full Text] [Related]
19. Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line treatment of Advanced Non-Small Cell lung cancer.
Ramoni D; Coco S; Rossi G; Dellepiane C; Bennicelli E; Santamaria S; Zinoli L; Tagliafico AS; Tagliamento M; Barletta G; Liberale L; Tirandi A; Minetti S; Bertolotto M; Montecucco F; Genova C; Carbone F
Lung; 2024 Apr; 202(2):197-210. PubMed ID: 38480620
[TBL] [Abstract] [Full Text] [Related]
20. Transfer learning-based PET/CT three-dimensional convolutional neural network fusion of image and clinical information for prediction of EGFR mutation in lung adenocarcinoma.
Shao X; Ge X; Gao J; Niu R; Shi Y; Shao X; Jiang Z; Li R; Wang Y
BMC Med Imaging; 2024 Mar; 24(1):54. PubMed ID: 38438844
[TBL] [Abstract] [Full Text] [Related]
[Next]
